Introduction
Materials and methods
Study design
Ethics
Patients
Intervention
Data collection
Outcomes
Statistical analysis
Results
Patients
Overall (n = 328) | Low Tidal Volume (n = 158) | Conventional Tidal Volume (n = 170) | p value | |
---|---|---|---|---|
Age (years) | 63 (55–71) | 63 (56–71) | 62 (55–71) | 0.667 |
Male gender (no. [%]) | 198 (60.4) | 99 (62.7) | 99 (58.2) | 0.431 |
Weight (kg) | 81.0 (69.8–96.0) | 81.0 (68.0–97.0) | 80.5 (71.8–95.8) | 0.959 |
BMI (kg/m2)a | 28.1 (24.5–32.6) | 28.1 (24.2–32.6) | 28.1 (24.8–32.3) | 0.739 |
ARISCAT score (no. / N [%])b | 32.5 (25.5–41.0) | 31.0 (26.0–41.0) | 34.0 (23.0–41.0) | 0.712 |
Low risk | 60 / 240 (25.0) | 25 / 119 (21.0) | 35 / 121 (28.9) | 0.288 |
Moderate risk | 158 / 240 (65.8) | 84 / 119 (70.6) | 74 / 121 (61.2) | |
High risk | 22 / 240 (9.2) | 10 / 119 (8.4) | 12 / 121 (9.9) | |
ASA physical status (no. / N [%])c | 0.563 | |||
1: healthy | 26 / 323 (8.0) | 10 / 156 (6.4) | 16 / 167 (9.6) | |
2: mild systemic disease | 142 / 323 (44.0) | 66 / 156 (42.3) | 76 / 167 (45.5) | |
3: severe systemic disease | 143 / 323 (44.3) | 73 / 156 (46.8) | 70 / 167 (41.9) | |
4: constant threat to life | 12 / 323 (3.7) | 7 / 156 (4.5) | 5 / 167 (3.0) | |
Baseline SpO2 (%) | 97 (96–98) | 97 (96–98) | 97 (96–98) | 0.619 |
Baseline HCO3 (mmol/L) | 26 (24.5–28) | 26 (24–28) | 26 (25–28) | 0.291 |
Baseline haemoglobin (g/dL) | 139 (123–150) | 141 (127–152) | 138 (122–149) | 0.083 |
Baseline creatinine (mg/dL) | 0.88 (0.74 − 1.07) | 0.89 (0.74 − 1.06) | 0.87 (0.72–1.08) | 0.615 |
Comorbidities (no. / N [%]) | ||||
Diabetes | 63 / 328 (19.2) | 28 / 158 (17.7) | 35 / 170 (20.6) | 0.575 |
Hypertension | 170 / 328 (51.8) | 81 / 158 (51.3) | 89 / 170 (52.4) | 0.912 |
Obesityd | 123 / 320 (38.4) | 55 / 153 (35.9) | 68 / 167 (40.7) | 0.421 |
Coronary artery disease | 54 / 328 (16.5) | 24 / 158 (15.2) | 30 / 170 (17.6) | 0.556 |
Chronic kidney disease | 28 / 328 (8.5) | 12 / 158 (7.6) | 16 / 170 (9.4) | 0.693 |
Chronic liver disease | 28 / 328 (8.5) | 9 / 158 (5.7) | 19 / 170 (11.2) | 0.112 |
Smoking | 58 / 328 (17.7) | 33 / 158 (20.9) | 25 / 170 (14.7) | 0.150 |
Chronic obstructive pulmonary disease | 39 / 328 (11.9) | 20 / 158 (12.7) | 19 / 170 (11.2) | 0.734 |
Asthma | 28 / 328 (8.5) | 10 / 158 (6.3) | 18 / 170 (10.6) | 0.235 |
Obstructive sleep apnoea | 38 / 328 (11.6) | 16 / 158 (10.1) | 22 / 170 (12.9) | 0.491 |
Recent respiratory infection | 6 / 328 (1.8) | 5 / 158 (3.2) | 1 / 170 (0.6) | 0.110 |
Emergency surgery (no. [%]) | 9 (2.7) | 7 / 158 (4.4) | 2 (1.2) | 0.094 |
Intraoperative procedures
Overall (n = 328) | Low Tidal Volume (n = 158) | Conventional Tidal Volume (n = 170) | p value | |
---|---|---|---|---|
Tidal volume | ||||
Absolute (mL) | 480 (400–630) | 400 (350–450) | 610 (520–700) | < 0.001 |
Adjusted (mL/kg PBW)a | 8.8 (6.0–10.0) | 6.0 (6.0–6.2) | 10.0 (9.9–10.1) | < 0.001 |
PEEP (cmH2O) | 5 (5–5) | 5 (5–5) | 5 (5–5) | – |
Peak pressure (cmH2O) | 27 (23–32) | 26 (22–30) | 29 (24–32) | < 0.001 |
Respiratory rate (breaths/min) | 14 (12–17) | 16 (14–18) | 12 (10–14) | < 0.001 |
SpO2 (%) | 97 (96–98) | 97 (95–98) | 97 (96–98) | 0.144 |
FiO2 (%) | 70 (50–96) | 70 (50–95) | 66.5 (50–99.5) | 0.580 |
etCO2 (%) | 40 (37–44) | 42 (40–47) | 39 (36–42) | < 0.001 |
Arterial blood gas after induction | ||||
pH | 7.40 (7.37–7.43) | 7.39 (7.35–7.41) | 7.42 (7.39–7.45) | < 0.001 |
PaO2 (mmHg) | 211 (158–274) | 203 (157–272) | 219 (164–275) | 0.256 |
PaCO2 (mmHg) | 41 (38–45) | 43 (40–47) | 39 (36–42) | < 0.001 |
HCO3 (mmol/L) | 25 (24–26) | 25 (24–27) | 25 (24–26) | 0.007 |
PaO2 / FiO2 (mmHg) | 412 (313–492) | 405 (300–481) | 417 (339–497) | 0.190 |
Haemoglobin (g/dL) | 127 (112–138) | 128 (114–139) | 125 (110–138) | 0.312 |
Base excess (mEq/L) | 1.0 (−0.3–2.0) | 0.8 (−0.4–2.0) | 1.0 (−0.1–2.0) | 0.896 |
Lactate (mmol/L) | 1.1 (0.9–1.4) | 1.1 (0.8–1.4) | 1.1 (0.9–1.5) | 0.197 |
Arterial blood gas prior to closure | ||||
pH | 7.34 (7.30–7.39) | 7.32 (7.27–7.36) | 7.37 (7.33–7.41) | < 0.001 |
PaO2 (mmHg) | 172 (132–219) | 168 (132–213) | 178 (133–221.8) | 0.316 |
PaCO2 (mmHg) | 45 (41–52) | 50 (43–55) | 42 (38–46) | < 0.001 |
HCO3 (mmol/L) | 24 (23–25.5) | 24 (23–26) | 24 (22–25) | 0.010 |
PaO2 / FiO2 (mmHg) | 367 (279–445) | 357 (264–438) | 371 (290–450) | 0.282 |
Haemoglobin (g/dL) | 124 (111–137) | 126 (113–140) | 122 (110–134) | 0.143 |
Base excess (mEq/L) | –1.0 (−2.4–0.1) | –1.0 (−2.6–0.0) | −0.9 (−2.2–0.5) | 0.205 |
Lactate (mmol/L) | 1.1 (0.8–1.5) | 1.0 (0.8–1.4) | 1.2 (0.9–1.6) | 0.039 |
Duration of surgery (minutes) | 185 (140–240) | 190 (145–240) | 184 (135–238) | 0.598 |
Use of regional anaesthesia (no. / N [%])b | 59 / 322 (18.3) | 29 / 156 (18.6) | 30 / 166 (18.1) | 0.999 |
Epidural | 0 / 322 (0.0) | 0 / 156 (0.0) | 0 / 166 (0.0) | – |
Spinal opioid | 26 / 322 (8.1) | 13 / 156 (8.3) | 13 / 166 (7.8) | 0.999 |
TAP/abdominal blockc | 22 / 322 (6.8) | 12 / 156 (7.7) | 10 / 166 (6.0) | 0.660 |
Otherd | 25 / 322 (7.8) | 11 / 156 (7.1) | 14 / 166 (8.4) | 0.682 |
Primary outcome
Overall (n = 328) | Low Tidal Volume (n = 158) | Conventional Tidal Volume (n = 170) | Unadjusted Analysis | Adjusted Analysis* | |||
---|---|---|---|---|---|---|---|
Absolute Difference (95% CI) | p value | Absolute Difference (95% CI) | p value | ||||
PPC within 7 days | 124 / 326 (38.0) | 52 / 157 (33.1) | 72 / 169 (42.6) | −9.48 (− 19.86 to 1.05)a | 0.076 | −10.36 (− 20.52 to − 0.20)a | 0.046 |
Pneumonia | 12 / 327 (3.7) | 6 / 158 (3.8) | 6 / 169 (3.6) | 0.25 (− 4.02 to 4.64)a | 0.906 | 0.12 (−3.98 to 4.22)a | 0.954 |
Respiratory failure | 54 / 327 (16.5) | 21 / 158 (13.3) | 33 / 169 (19.5) | −6.24 (−14.26 to 1.81)a | 0.126 | −6.71 (− 14.66 to 1.25)a | 0.098 |
Pleural effusion | 31 / 326 (9.5) | 15 / 158 (9.5) | 16 / 168 (9.5) | − 0.03 (− 6.48 to 6.49)a | 0.993 | −0.31 (−6.61 to 5.99)a | 0.924 |
Atelectasis | 84 / 327 (25.7) | 36 / 157 (22.9) | 48 / 170 (28.2) | −5.31 (−14.70 to 4.18)a | 0.270 | −6.09 (−15.40 to 3.23)a | 0.199 |
Pneumothorax | 0 / 327 (0.0) | 0 / 158 (0.0) | 0 / 169 (0.0) | – | – | – | – |
Bronchospasm | 5 / 327 (1.5) | 2 / 158 (1.3) | 3 / 169 (1.8) | −0.51 (−3.57 to 2.48)a | 0.706 | − 0.51 (− 3.20 to 2.19)a | 0.711 |
Pulmonary congestion | 6 / 327 (1.8) | 2 / 158 (1.3) | 4 / 169 (2.4) | −1.10 (−4.43 to 2.02)a | 0.454 | −1.20 (− 4.14 to 1.75)a | 0.424 |
Unplanned NIV or IMV | 7 / 327 (2.1) | 3 / 158 (1.9) | 4 / 169 (2.4) | −0.47 (−3.93 to 2.98)a | 0.769 | −0.43 (−3.55 to 2.69)a | 0.786 |
PPC during hospital stay | 128 / 324 (39.5) | 53 / 157 (33.8) | 75 / 167 (44.9) | −11.15 (−21.60 to −0.52)a | 0.039 | − 12.13 (− 22.35 to − 1.91)a | 0.020 |
Pulmonary embolism | 2 / 324 (0.6) | 1 / 158 (0.6) | 1 / 166 (0.6) | 0.03 (−2.16 to 2.31)a | 0.972 | 0.07 (−1.63 to 1.77)a | 0.933 |
Acute respiratory distress syndrome | 0 / 324 (0.0) | 0 / 158 (0.0) | 0 / 166 (0.0) | – | – | – | – |
SIRS | 1 / 326 (0.3) | 0 / 157 (0.0) | 1 / 169 (0.6) | −0.60 (−1.80 to 0.62)a | 0.336 | −0.58 (−1.78 to 0.63)a | 0.347 |
Sepsis | 11 / 327 (3.4) | 7 / 158 (4.4) | 4 / 169 (2.4) | 2.06 (−1.92 to 6.45)a | 0.305 | 2.22 (−1.72 to 6.16)a | 0.269 |
Acute kidney injury | 24 / 228 (10.5) | 11 / 115 (9.6) | 13 / 113 (11.5) | −1.94 (− 10.14 to 6.15)a | 0.633 | − 1.60 (−9.61 to 6.42)a | 0.695 |
Risk | 18 / 228 (7.9) | 8 / 115 (7.0) | 10 / 113 (8.8) | ||||
Injury | 1 / 228 (0.4) | 1 / 115 (0.9) | 0 / 113 (0.0) | ||||
Failure | 5 / 228 (2.2) | 2 / 115 (1.7) | 3 / 113 (2.7) | ||||
Wound infection | 6 / 325 (1.8) | 3 / 158 (1.9) | 3 / 167 (1.8) | 0.10 (−3.13 to 3.44)a | 0.945 | −0.09 (−3.00 to 2.83)a | 0.952 |
Intraoperative need of vasopressor | 269 / 322 (83.5) | 130 / 156 (83.3) | 139 / 166 (83.7) | −0.40 (−8.59 to 7.72)a | 0.923 | −0.80 (−8.85 to 7.25)a | 0.845 |
Unplanned ICU admission | 15 / 320 (4.7) | 8 / 155 (5.2) | 7 / 165 (4.2) | 0.92 (−3.85 to 5.87)a | 0.698 | 1.03 (−3.62 to 5.69)a | 0.663 |
Need for MET call | 26 / 327 (8.0) | 12 / 158 (7.6) | 14 / 169 (8.3) | −0.69 (−6.66 to 5.33)a | 0.818 | −0.78 (−6.62 to 5.06)a | 0.793 |
Length of stay | |||||||
In ICU (hours) | 27.3 ± 33.6 | 29.4 ± 31.8 | 26.0 ± 35.1 | 3.36 (−15.09 to 21.82)b | 0.716 | 6.51 (−12.04 to 25.06)b | 0.484 |
Median (IQR) | 15 (13 to 27) | 17 (12 to 28) | 15 (13 to 20) | ||||
In hospital (days) | 6.7 ± 6.0 | 7.0 ± 6.4 | 6.4 ± 5.7 | 0.64 (−0.66 to 1.96)b | 0.333 | 0.54 (−0.72 to 1.81)b | 0.399 |
Median (IQR) | 5 (3 to 8) | 5 (3 to 8) | 4 (3 to 7) | ||||
In-hospital mortality | 5 / 328 (1.5) | 3 / 158 (1.9) | 2 / 170 (1.2) | 0.72 (−1.95 to 3.39)a | 0.595 | 0.78 (− 1.86 to 3.42)a | 0.562 |